Daiichi Sankyo Company, Limited

4568.T
Drug Manufacturers - General
2026/09/04 Updated
Market Cap: $32.8B (¥5.1T)
Stock Price: $18.01 (¥2,814)
Exchange Rate: 1 USD = ¥156.25

(Disclosure item changes) Notice regarding the effectiveness date change of Daiichi Sankyo Business Associates’ absorption-type merger (simplified merger, abbreviated merger)

This notice changes the effective date of the absorption-type merger of Daiichi Sankyo Business Associates. The dates for the merger contract signing and the effective date have shifted to 2027/2028, with a minor impact expected on consolidated results.

Importance:
Page Updated: August 28, 2026
IR Disclosure Date: August 28, 2026

Key Figures

  • Post-merger date (effective date): July 1, 2028 (planned)
  • Post-merger contract signing date: February 29, 2028 (planned)
  • Scope of impact: Minor on consolidated results

AI要約

Key points of the change

The effective date of this merger is postponed to address preparation delays. The changes revise the merger contract signing date and the merger date (effective date) to 2027 and 2028 respectively. No other changes.

Impact on investors and future outlook

This is a rescheduling of the absorption merger; the impact on consolidated results is expected to be minor. Further progress will be disclosed again, and the company will monitor whether the schedule changes affect performance.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Daiichi Sankyo Company, Limited

Company overview · Stock price · Financial data · All IR

View company page →